C. Zander

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

W.-K. Hofmann, Gerhard Heil, C. Zander et al. · Annals of Hematology · 2004 · 57 citations

Medicine, Hematology, Oncology +17

Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all- trans -retinoic acid, granulocyte colony-stimulating factor, erythropoietin and α-tocopherol

Arnold Ganser, Alexander Maurer, Christel Contzen et al. · Annals of Hematology · 1996 · 40 citations

Medicine, Hematology, Oncology +13

Treatment of patients with low-risk myelodysplastic syndromes using a combination of all- trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

W.-K. Hofmann, Arnold Ganser, G. Seipelt et al. · Annals of Hematology · 1999 · 35 citations

Medicine, Hematology, Pharmacotherapy +10

A phase I study of INNO-406, a dual inhibitor of Abl and Lyn kinases, in adult patients with Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) or acute lymphocytic leukemia (ALL) relapsed, refractory, or intolerant of imatinib

Adam R. Craig, Hagop M. Kantarjian, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2007 · 17 citations

Medicine, Hematology, Pharmacology +14

SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.

Eising Eg, Müller Tt, C. Zander et al. · PubMed · 1997 · 12 citations

Medicine, Neuroscience, Pharmacology +16